Key Site Information

For legal agreements (Confidential Disclosure Agreements (CDAs) and Clinical Trial Research Agreements (CTRAs), the Murdoch Children’s Research Institute is the Institution and The Royal Children’s Hospital (RCH) is the site.  MCRI and RCH have a legal agreement where MCRI is responsible for all clinical trials on campus and RCH is responsible for clinical care.  As the custodians of research, MCRI is the contracting party.  RCH is the site at which the study is conducted and participants recruited.

Site Name:                                     The Royal Children’s Hospital (ABN: 35 655 720 546)

Administering Institution:          Murdoch Children’s Research Institute (ABN: 21 006 566 972)

Address:                                         50 Flemington Road, Parkville VIC 3052

Therapeutic Area and Patient Population: Paediatrics (< 18 years old); Phase 1 – IV trials

Gastroenterology and Hepatology, Haematology, Neurology, Nephrology, Endocrinology and Diabetes, Emergency Medicine, Dermatology, Metabolic Medicine, Neurodevelopment and Disability, Anaesthetics and Pain Management, Allergy and Immunology, Vaccines, Developmental Disorders,  Infectious Diseases, Rheumatology

For oncology trials, please contact RCH Children's Cancer Centre directly at [email protected].

Ethics Committee:  The Royal Children’s Hospital Human Research Ethics Committee (NHMRC Registration: EC00238) https://www.rch.org.au/ethics/

Meeting Frequency: Monthly.  

Submission Package should include (Protocol, Investigators Brochure, Parent/Guardian and Participant Informed Consent Forms (Note: RCH HREC prefers the use of CT:IQ InFORM template) and study manuals required one month before the RCH HREC Submission Closing Date.  The study budget must be agreed before the study can be submitted.

Local Laboratory:  The Royal Children’s Hospital Laboratory Services: NATA Accredited